Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHGDH | O43175 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.33 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10063830 | 1.00 | PHGDH (0.45) | PHGDHCYP1A2TDP1POLBSMN1; SMN2 | |
| Methylpiperazine SCHEMBL11824164 | 1.00 | PHGDH (0.45) | PHGDHCYP1A2TDP1POLBSMN1; SMN2 | |
| SCHEMBL31503132 | 1.00 | PHGDH (0.45) | PHGDHCYP1A2TDP1POLBSMN1; SMN2 | |
| Bromide SCHEMBL8214911 | 0.97 | PHGDH (0.43) | PHGDHCYP1A2TDP1POLBSMN1; SMN2 | |
| SCHEMBL16289999 | 0.97 | PHGDH (0.43) | PHGDHCYP1A2TDP1POLBSMN1; SMN2 | |
| SCHEMBL154155 | 0.96 | PHGDH (0.41) | PHGDHPOLBSMN1; SMN2CXCR4ADRB1 | |
| Methylpiperazine SCHEMBL12678259 | 0.96 | — | — | |
| Methylpiperazine SCHEMBL54849 | 0.96 | — | — | |
| Methylpiperazine SCHEMBL1363 | 0.96 | — | — | |
| Methylpiperazine SCHEMBL12678256 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116163143-B | Low-temperature multifunctional scouring agent and application thereof in low-temperature boiling and bleaching one-bath process | 多恩生物科技有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-116163143-A | Low-temperature multifunctional scouring agent and application thereof in low-temperature boiling and bleaching one-bath process | 多恩生物科技有限公司 | 2023-05-26 | — | — | CN | claimed |
| EP-0970951-A1 | A manganese oxidation catalyst, a method for its preparation and use thereof for catalytic epoxidation, catalytic cis-dihydroxylation and combined expoxidation-cis-dihydroxylation of olefins | K.U. Leuven Research & Development (BE) | 2000-01-12 | — | — | EP | claimed |
| US-12577505-B2 | Granules comprising protonated triazacyclic compounds and bleaching agent and cleaning agent comprising the same | CATEXEL GMBH (DE) | 2026-03-17 | — | — | US | disclosed |
| US-20260027243-A1 | AMPHIPHILIC COMPOUNDS FOR ATTENUATING NEUROTOXICITY OF AMYLOID-beta OLIGOMERS AND DIAGNOSTIC METHODS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250281419-A1 | LIPID AMINES | ARES CAPITAL CORPORATION, AS AGENT | 2025-09-11 | — | — | US | disclosed |
| US-20250235531-A1 | MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS | MODERNATX, INC. (US) | 2025-07-24 | — | — | US | disclosed |
| EP-4256018-B1 | GRANULES COMPRISING PROTONATED TRIAZACYCLIC COMPOUNDS AND BLEACHING AGENT AND CLEANING AGENT COMPRISING THE SAME | WeylChem Performance Products GmbH (DE) | 2025-07-16 | — | — | EP | disclosed |
| EP-4512881-A1 | LIQUID FORMULATION COMPRISING AN ALCOHOL AND HIGHLY WATER SOLUBLE MANGANESE COMPLEX SALT CATALYST, BLEACHING FORMULATION AND CLEANING AGENT COMPRISING THE SAME | Catexel GmbH (DE) | 2025-02-26 | — | — | EP | disclosed |
| EP-4512880-A1 | LIQUID FORMULATION COMPRISING AN ALCOHOL AND HIGHLY WATER SOLUBLE MANGANESE COMPLEX SALT CATALYST, BLEACHING FORMULATION AND CLEANING AGENT COMPRISING THE SAME | WeylChem Performance Products GmbH (DE) | 2025-02-26 | — | — | EP | disclosed |
| CN-119490893-A | Liquid formulations comprising alcohol and high water-soluble manganese complex salt catalysts, bleaching formulations and cleaners comprising the same | 卡特赛尔有限公司 | 2025-02-21 | — | — | CN | disclosed |
| WO-2004067689-A1 | DETERGENT COMPOSITIONS | UNILEVER PLC (GB) | 2004-08-12 | — | — | WO | disclosed |
| US-20040033891-A1 | Cationic group-3 catalyst system | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-02-19 | — | — | US | disclosed |
| EP-1337536-A1 | CATIONIC GROUP-3 CATALYST SYSTEM | ExxonMobil Chemical Patents Inc. (US) | 2003-08-27 | — | — | EP | disclosed |
| US-6545147-B1 | E.g., a bicyclic manganese complex containing a bridging 2,6-bis(1,4,7-triazacyclononan-1-ylmethyl)4-methylphenoxide ligand, two bridging acetate groups and two perchlorate anions | CLARIANT GMBH (DE) | 2003-04-08 | — | — | US | disclosed |
| WO-2002032909-A1 | CATIONIC GROUP-3 CATALYST SYSTEM | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2002-04-25 | — | — | WO | disclosed |
| EP-1083173-A2 | Metal complexes with bleaching activity | Clariant GmbH (DE) | 2001-03-14 | — | — | EP | disclosed |
| US-6063637-A | SENSING MATERIAL OF METAL COMPLEXES HAVING AT LEAST TWO COORDINATION SITES FOR BINDING TARGET AND A DETECTOR FOR MEASURING THE PROTONS OR HYDROXIDE IONS RELEASED FROM THE SENSING MATERIAL WHEN ANALYTE IS BOUND | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2000-05-16 | — | — | US | disclosed |
| EP-0970951-A1 | A manganese oxidation catalyst, a method for its preparation and use thereof for catalytic epoxidation, catalytic cis-dihydroxylation and combined expoxidation-cis-dihydroxylation of olefins | K.U. Leuven Research & Development (BE) | 2000-01-12 | — | — | EP | disclosed |
| EP-0902021-A2 | Cyclic polyamine salts | Clariant GmbH (DE) | 1999-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250235531-A1 | MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS | MUC1, RNMT, FABP2 | PHGDH 4401/4885CYP1A2 3732/4885TDP1 3192/4885 |
| US-20260027243-A1 | AMPHIPHILIC COMPOUNDS FOR ATTENUATING NEUROTOXICITY OF AMYLOID-beta OLIGOMERS AND DIAGNOSTIC METHODS | APP, BACE1, PSEN1 | PHGDH 4386/4885CYP1A2 4126/4885TDP1 3959/4885 |
| US-20040033891-A1 | Cationic group-3 catalyst system | COG3, ORC3, LIG3 | PHGDH 3449/4885CYP1A2 4044/4885TDP1 4378/4885 |
| US-20250281419-A1 | LIPID AMINES | SGMS1, PHOSPHO1, SGMS2 | PHGDH 2052/4885CYP1A2 555/4885TDP1 2561/4885 |
| US-12577505-B2 | Granules comprising protonated triazacyclic compounds and bleaching agent and cleaning agent comprising the same | HBG2, HBG1, BLM | PHGDH 1652/4885CYP1A2 1442/4885TDP1 2527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.